Development depth and industrial manufacturing capability in Peristeri, Athens.
7 Kyklaminon, 12137 Peristeri
R&D, analytical work, pilot support, QC and GMP operations for selected non-sterile liquid and semisolid products. Site allocation follows the approved scope and the project’s technical requirements.
3–5 Stylianou Gonata, 12133 Peristeri
Production capability authorised by EOF under protocol 5986, dated 11 June 2026, covering the specified non-sterile pharmaceutical, supplement, medical-device and cosmetic forms.
Two complementary sites broaden scheduling and development options. Alternate-site manufacturing requires the appropriate technical transfer, qualification, capacity and regulatory approvals; it is established within the supply agreement.
Request quality documentation